Literature DB >> 22927401

Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin.

Nicolas Bonnet1, Simon J Conway, Serge L Ferrari.   

Abstract

Periostin (Postn) is a matricellular protein preferentially expressed by osteocytes and periosteal osteoblasts in response to mechanical stimulation and parathyroid hormone (PTH). Whether and how periostin expression influences bone anabolism, however, remains unknown. We investigated the skeletal response of adult Postn(-/-) and Postn(+/+) mice to intermittent PTH. Compared with Postn(+/+), Postn(-/-) mice had a lower bone mass, cortical bone volume, and strength response to PTH. PTH-stimulated bone-forming indices were all significantly lower in Postn(-/-) mice, particularly at the periosteum. Furthermore, in vivo stimulation of Wnt-β-catenin signaling by PTH, as evaluated in TOPGAL reporter mice, was inhibited in the absence of periostin (TOPGAL;Postn(-/-) mice). PTH stimulated periostin and inhibited MEF2C and sclerostin (Sost) expression in bone and osteoblasts in vitro. Recombinant periostin also suppressed Sost expression, which was mediated through the integrin αVβ3 receptor, whereas periostin-blocking antibody prevented inhibition of MEF2C and Sost by PTH. In turn, administration of a Sost-blocking antiboby partially restored the PTH-mediated increase in bone mass in Postn(-/-) mice. In addition, primary osteoblasts from Postn(-/-) mice showed a lower proliferation, mineralization, and migration, both spontaneously and in response to PTH. Osteoblastic gene expression levels confirmed a defect of Postn(-/-) osteoblast differentiation with and without PTH, as well as an increased osteoblast apoptosis in the absence of periostin. These data elucidate the complex role of periostin on bone anabolism, through the regulation of Sost, Wnt-β-catenin signaling, and osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22927401      PMCID: PMC3443161          DOI: 10.1073/pnas.1203085109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide.

Authors:  Robert Lindsay; Felicia Cosman; Hua Zhou; Mathias P Bostrom; Victor W Shen; JoAnn D Cruz; Jeri W Nieves; David W Dempster
Journal:  J Bone Miner Res       Date:  2005-11-21       Impact factor: 6.741

2.  Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice.

Authors:  Philippe Clément-Lacroix; Minrong Ai; Frederic Morvan; Sergio Roman-Roman; Béatrice Vayssière; Cecille Belleville; Kenneth Estrera; Matthew L Warman; Roland Baron; Georges Rawadi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

3.  Co-treatment of PTH with osteoprotegerin or alendronate increases its anabolic effect on the skeleton of oophorectomized mice.

Authors:  Rana Samadfam; Qingwen Xia; David Goltzman
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

4.  Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray.

Authors:  Jude E Onyia; Leah M Helvering; Lawrence Gelbert; Tao Wei; Shuguang Huang; Peining Chen; Ernst R Dow; Avudaiappan Maran; Minzhi Zhang; Sutada Lotinun; Xi Lin; David L Halladay; Rebecca R Miles; Nalini H Kulkarni; Emily M Ambrose; Yanfei L Ma; Charles A Frolik; Masahiko Sato; Henry U Bryant; Russell T Turner
Journal:  J Cell Biochem       Date:  2005-05-15       Impact factor: 4.429

5.  beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.

Authors:  Mary L Bouxsein; Dominique D Pierroz; Vaida Glatt; Deborah S Goddard; Fanny Cavat; Renée Rizzoli; Serge L Ferrari
Journal:  J Bone Miner Res       Date:  2004-12-06       Impact factor: 6.741

6.  Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone.

Authors:  John A Robinson; Moitreyee Chatterjee-Kishore; Paul J Yaworsky; Diane M Cullen; Weiguang Zhao; Christine Li; Yogendra Kharode; Linda Sauter; Philip Babij; Eugene L Brown; Andrew A Hill; Mohammed P Akhter; Mark L Johnson; Robert R Recker; Barry S Komm; Frederick J Bex
Journal:  J Biol Chem       Date:  2006-08-14       Impact factor: 5.157

7.  periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype.

Authors:  Hector Rios; Shrinagesh V Koushik; Haiyan Wang; Jian Wang; Hong-Ming Zhou; Andrew Lindsley; Rhonda Rogers; Zhi Chen; Manabu Maeda; Agnieszka Kruzynska-Frejtag; Jian Q Feng; Simon J Conway
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

8.  Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism.

Authors:  Sjur Reppe; Lis Stilgren; Ole K Olstad; Kim Brixen; Lise Sofie Nissen-Meyer; Kaare M Gautvik; Bo Abrahamsen
Journal:  Bone       Date:  2006-03-03       Impact factor: 4.398

9.  Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear.

Authors:  Kin-Hing William Lau; Sonia Kapur; Chandrasekhar Kesavan; David J Baylink
Journal:  J Biol Chem       Date:  2006-02-03       Impact factor: 5.157

10.  Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk.

Authors:  S-M Xiao; Y Gao; C-L Cheung; C H Bow; K-S Lau; P C Sham; K C B Tan; A W C Kung
Journal:  Osteoporos Int       Date:  2012-01-04       Impact factor: 4.507

View more
  53 in total

1.  The anabolic effect of PTH on bone is mediated by periostin.

Authors: 
Journal:  Bonekey Rep       Date:  2012-11-14

2.  Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.

Authors:  Changjun Li; Weishan Wang; Liang Xie; Xianghang Luo; Xu Cao; Mei Wan
Journal:  Ann N Y Acad Sci       Date:  2015-04-02       Impact factor: 5.691

Review 3.  Regulatory mechanisms of sclerostin expression during bone remodeling.

Authors:  Masanori Koide; Yasuhiro Kobayashi
Journal:  J Bone Miner Metab       Date:  2018-10-24       Impact factor: 2.626

4.  Macrophage-lineage TRAP+ cells recruit periosteum-derived cells for periosteal osteogenesis and regeneration.

Authors:  Bo Gao; Ruoxian Deng; Yu Chai; Hao Chen; Bo Hu; Xiao Wang; Shouan Zhu; Yong Cao; Shuangfei Ni; Mei Wan; Liu Yang; Zhuojing Luo; Xu Cao
Journal:  J Clin Invest       Date:  2019-04-04       Impact factor: 14.808

5.  Influence of Mechanical Force on Bone Matrix Proteins in Ovariectomised Mice and Osteoblast-like MC3T3-E1 Cells.

Authors:  Meng Zhang; Shintaro Ishikawa; Tomoko Inagawa; Hideshi Ikemoto; Shiyu Guo; Masataka Sunagawa; Tadashi Hisamitsu
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

6.  Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis.

Authors:  Fatma Gossiel; Jessica R Scott; Margaret A Paggiosi; Kim E Naylor; Eugene V McCloskey; Nicola F A Peel; Jennifer S Walsh; Richard Eastell
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

7.  The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b.

Authors:  Jau-Yi Li; Lindsey D Walker; Abdul Malik Tyagi; Jonathan Adams; M Neale Weitzmann; Roberto Pacifici
Journal:  J Bone Miner Res       Date:  2014-01       Impact factor: 6.741

8.  RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass.

Authors:  Nicolas Bonnet; Lucie Bourgoin; Emmanuel Biver; Eleni Douni; Serge Ferrari
Journal:  J Clin Invest       Date:  2019-05-23       Impact factor: 14.808

Review 9.  The Utility of Biomarkers in Osteoporosis Management.

Authors:  Patrick Garnero
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 10.  Functions of Periostin in dental tissues and its role in periodontal tissues' regeneration.

Authors:  Juan Du; Minqi Li
Journal:  Cell Mol Life Sci       Date:  2017-09-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.